Literature DB >> 19937730

MAPK pathway activation and the origins of pediatric low-grade astrocytomas.

Ruth G Tatevossian1, Andrew R J Lawson, Tim Forshew, Guy F L Hindley, David W Ellison, Denise Sheer.   

Abstract

Low-grade astrocytomas (LGAs) are the most common type of brain tumor in children. Until recently, very little was known about the underlying biology and molecular genetics of these tumors. However, within the past year a number of studies have shown that the MAPK pathway is constitutively activated in a high proportion of LGAs. Several genetic aberrations which generate this deregulation of the MAPK pathway have been identified, most notably gene fusions between KIAA1549 and BRAF. In this review we summarize these findings, discuss how these gene fusions may arise and consider possible implications for diagnosis and treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19937730     DOI: 10.1002/jcp.21978

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  38 in total

1.  The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primates.

Authors:  AeRang Kim; Cindy McCully; Rafael Cruz; Diane E Cole; Elizabeth Fox; Frank M Balis; Brigitte C Widemann
Journal:  Invest New Drugs       Date:  2010-11-12       Impact factor: 3.850

2.  MYB upregulation and genetic aberrations in a subset of pediatric low-grade gliomas.

Authors:  Ruth G Tatevossian; Bo Tang; James Dalton; Tim Forshew; Andrew R Lawson; Jing Ma; Geoff Neale; Sheila A Shurtleff; Simon Bailey; Amar Gajjar; Suzanne J Baker; Denise Sheer; David W Ellison
Journal:  Acta Neuropathol       Date:  2010-11-03       Impact factor: 17.088

3.  Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target.

Authors:  Marianne Hütt-Cabezas; Matthias A Karajannis; David Zagzag; Smit Shah; Iren Horkayne-Szakaly; Elisabeth J Rushing; J Douglas Cameron; Deepali Jain; Charles G Eberhart; Eric H Raabe; Fausto J Rodriguez
Journal:  Neuro Oncol       Date:  2013-11-06       Impact factor: 12.300

4.  Detection of KIAA1549-BRAF fusion transcripts in formalin-fixed paraffin-embedded pediatric low-grade gliomas.

Authors:  Yongji Tian; Benjamin E Rich; Natalie Vena; Justin M Craig; Laura E Macconaill; Veena Rajaram; Stewart Goldman; Hala Taha; Madeha Mahmoud; Memet Ozek; Aydin Sav; Janina A Longtine; Neal I Lindeman; Levi A Garraway; Azra H Ligon; Charles D Stiles; Sandro Santagata; Jennifer A Chan; Mark W Kieran; Keith L Ligon
Journal:  J Mol Diagn       Date:  2011-08-30       Impact factor: 5.568

Review 5.  Review of low-grade gliomas in children--evolving molecular era and therapeutic insights.

Authors:  Soumen Khatua; Jason Wang; Veena Rajaram
Journal:  Childs Nerv Syst       Date:  2015-02-27       Impact factor: 1.475

Review 6.  To BRAF or not to BRAF: is that even a question anymore?

Authors:  Craig Horbinski
Journal:  J Neuropathol Exp Neurol       Date:  2013-01       Impact factor: 3.685

7.  Concomitant KIAA1549-BRAF fusion and IDH mutation in Pediatric spinal cord astrocytoma: a case report and literature review.

Authors:  Mengxue Sun; Leiming Wang; Dehong Lu; Zhilian Zhao; Lianghong Teng; Weimin Wang; Yueshan Piao
Journal:  Brain Tumor Pathol       Date:  2021-02-28       Impact factor: 3.298

Review 8.  The molecular biology of WHO grade I astrocytomas.

Authors:  Nicholas F Marko; Robert J Weil
Journal:  Neuro Oncol       Date:  2012-10-22       Impact factor: 12.300

9.  BRAF alterations in pediatric low grade gliomas and mixed neuronal-glial tumors.

Authors:  Efthymios Dimitriadis; George A Alexiou; Panagiota Tsotsou; Efthymia Simeonidi; Kalliopi Stefanaki; Amalia Patereli; Neofytos Prodromou; Nikolaos Pandis
Journal:  J Neurooncol       Date:  2013-04-24       Impact factor: 4.130

10.  Relative ADC and Location Differ between Posterior Fossa Pilocytic Astrocytomas with and without Gangliocytic Differentiation.

Authors:  J H Harreld; S N Hwang; I Qaddoumi; R G Tatevossian; X Li; J Dalton; K Haupfear; Y Li; D W Ellison
Journal:  AJNR Am J Neuroradiol       Date:  2016-07-28       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.